All stories tagged :

Pr Newswire

Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and...

Tháng mười một 12

Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate...

12 giờ ago

Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline...

12 giờ ago

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and...

12 giờ ago

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business...

12 giờ ago

RWA.LTD Secures Multi-Million Dollar Angel Investment to Accelerate the Development of...

12 giờ ago

World Gym Q3 Results: EPS Jumps 82.5% on Record Revenue

12 giờ ago

d-Matrix Raises $275 Million to Power the Age of AI Inference

12 giờ ago

China Automotive Systems Reports 77.8% EPS Growth in the Third Quarter...

12 giờ ago

IBM Delivers New Quantum Processors, Software, and Algorithm Breakthroughs on Path...

12 giờ ago

BPGbio Appoints John Dvor as Executive Vice President, Corporate Development

24 giờ ago

1 2 3 4 … 810 811 812 Page 1 of 812

Featured

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and...

12 giờ ago

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business...

12 giờ ago

RWA.LTD Secures Multi-Million Dollar Angel Investment to Accelerate the Development of...

12 giờ ago

World Gym Q3 Results: EPS Jumps 82.5% on Record Revenue

12 giờ ago

12 giờ ago

Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and...

Meg Alexander appointed Chief Executive Officer effective January 1, 2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board of DirectorsNext-generation GABA-aminotransferase (GABA-AT) inhibitor, OV329, demonstrated strong inhibitory activity and a potential best-in-category safety profile in a Phase 1 study, supporting advancement into planned Phase 2...